ASTM

AASTROM BIOSCIENCES INCCIK 887359 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for ASTM PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for ASTM

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Orlando Daniel	Chief Operating Officer	3	$25.0K	$0	2014-09-16
Colangelo Dominick	President and CEO	2	$51.0K	$0	2014-09-16
MICHEL GERARD J	CFO and VP, Corp. Development	2	$51.0K	$0	2014-09-16
Eastern Capital LTD	10% Owner	2	$0	$0	2014-07-09
Hagen Heidi	Director	4	$0	$0	2014-05-07
Rubino Alan L	Director	4	$0	$0	2014-05-07
SIMS NELSON M	Director	3	$0	$0	2014-05-07
ZERBE ROBERT L MD	Director	4	$0	$0	2014-05-07
Elliston Michael W.	Controller	1	$0	$0	2014-01-03
CRESSWELL RONALD M	Director	2	$0	$0	2013-05-02
Urschel Harold C Jr	Director	1	$0	$0	2012-10-23
MAYLEBEN TIMOTHY M	President and CEO	5	$0	$0	2012-08-29
Watling Sharon	VP Clinical Development	3	$0	$0	2012-06-25
Bartel Ronnda	Chief Scientific Officer	3	$0	$0	2012-06-25
Gibson Brian	Vice President	2	$0	$0	2012-05-03
Durbin Scott	CFO	1	$0	$72.0K	2012-01-04

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Orlando Daniel	Chief Operating Officer	P Buy	2014-09-16	2014-09-17	9,804	$2.55	$25.0K	9,804	SEC↗
Colangelo Dominick	President and CEO	P Buy	2014-09-16	2014-09-17	20,000	$2.55	$51.0K	20,000	SEC↗
MICHEL GERARD J	CFO and VP, Corp. Developmen	P Buy	2014-09-16	2014-09-17	20,000	$2.55	$51.0K	20,000	SEC↗
Eastern Capital LTD	10% Owner	O Exercise OTM deriv	2014-07-09	2014-07-11	362,500	—	$0	0	SEC↗
Eastern Capital LTD	10% Owner	O Exercise OTM	2014-07-09	2014-07-11	362,500	$4.80	$1.74M	787,489	SEC↗
MICHEL GERARD J	CFO and VP, Corp. Developmen	A Award deriv	2014-06-11	2014-06-13	45,000	$4.36	$196.2K	45,000	SEC↗
Hagen Heidi	Director	A Award deriv	2014-05-07	2016-05-06	3,000	—	$0	3,000	SEC↗
Rubino Alan L	Director	A Award deriv	2014-05-07	2016-05-06	3,000	—	$0	3,000	SEC↗
ZERBE ROBERT L MD	Director	A Award deriv	2014-05-07	2016-05-06	3,000	—	$0	3,000	SEC↗
SIMS NELSON M	Director	A Award deriv	2014-05-07	2014-11-10	3,000	$4.12	$12.4K	3,000	SEC↗
Hagen Heidi	Director	A Award deriv	2014-05-07	2014-06-24	3,000	$4.12	$12.4K	3,000	SEC↗
ZERBE ROBERT L MD	Director	A Award deriv	2014-05-07	2014-06-24	3,000	$4.12	$12.4K	3,000	SEC↗
Rubino Alan L	Director	A Award deriv	2014-05-07	2014-06-24	300	$4.12	$1.2K	3,000	SEC↗
Orlando Daniel	Chief Operating Officer	A Award deriv	2014-01-03	2016-05-06	33,000	—	$0	33,000	SEC↗
Orlando Daniel	Chief Operating Officer	A Award deriv	2014-01-03	2014-01-08	33,000	$3.57	$117.8K	33,000	SEC↗
Elliston Michael W.	Controller	A Award deriv	2014-01-03	2014-01-08	1,400	$3.57	$5.0K	1,400	SEC↗
Colangelo Dominick	President and CEO	A Award deriv	2014-01-03	2014-01-08	55,000	$3.57	$196.3K	55,000	SEC↗
Hagen Heidi	Director	A Award deriv	2013-08-23	2013-08-27	30,000	—	$0	30,000	SEC↗
Hagen Heidi	Director	A Award deriv	2013-08-23	2013-08-27	45,000	—	$0	45,000	SEC↗
ZERBE ROBERT L MD	Director	A Award deriv	2013-05-02	2013-05-03	60,000	$0.53	$31.8K	60,000	SEC↗
SIMS NELSON M	Director	A Award deriv	2013-05-02	2013-05-03	60,000	$0.53	$31.8K	60,000	SEC↗
Rubino Alan L	Director	A Award deriv	2013-05-02	2013-05-03	60,000	$0.53	$31.8K	60,000	SEC↗
CRESSWELL RONALD M	Director	A Award deriv	2013-05-02	2013-05-03	60,000	$0.53	$31.8K	60,000	SEC↗
ZERBE ROBERT L MD	Director	A Award deriv	2012-10-23	2012-10-25	60,000	$1.47	$88.2K	60,000	SEC↗
Urschel Harold C Jr	Director	A Award deriv	2012-10-23	2012-10-25	60,000	$1.47	$88.2K	60,000	SEC↗
SIMS NELSON M	Director	A Award deriv	2012-10-23	2012-10-25	60,000	$1.47	$88.2K	60,000	SEC↗
Rubino Alan L	Director	A Award deriv	2012-10-23	2012-10-25	60,000	$1.47	$88.2K	60,000	SEC↗
CRESSWELL RONALD M	Director	A Award deriv	2012-10-23	2012-10-25	60,000	$1.47	$88.2K	60,000	SEC↗
MAYLEBEN TIMOTHY M	President and CEO	A Award deriv	2012-08-29	2012-08-30	283,000	$1.67	$472.6K	283,000	SEC↗
MAYLEBEN TIMOTHY M	President and CEO	D To issuer deriv	2012-08-29	2012-08-30	317,000	$1.49	$472.3K	78,000	SEC↗
Watling Sharon	VP Clinical Development	D To issuer deriv	2012-06-25	2012-06-27	151,937	$2.26	$343.4K	69,063	SEC↗
Watling Sharon	VP Clinical Development	A Award deriv	2012-06-25	2012-06-27	151,937	$2.26	$343.4K	151,937	SEC↗
Bartel Ronnda	Chief Scientific Officer	D To issuer deriv	2012-06-25	2012-06-27	107,594	$2.26	$243.2K	48,906	SEC↗
Bartel Ronnda	Chief Scientific Officer	A Award deriv	2012-06-25	2012-06-27	107,594	$2.26	$243.2K	107,594	SEC↗
MAYLEBEN TIMOTHY M	President and CEO	D To issuer deriv	2012-06-25	2012-06-27	481,164	$2.26	$1.09M	218,711	SEC↗
MAYLEBEN TIMOTHY M	President and CEO	A Award deriv	2012-06-25	2012-06-27	481,164	$2.26	$1.09M	481,164	SEC↗
MAYLEBEN TIMOTHY M	President and CEO	A Award deriv	2012-05-03	2012-05-07	520,000	$2.49	$1.29M	520,000	SEC↗
Watling Sharon	VP Clinical Development	A Award deriv	2012-05-03	2012-05-07	117,000	$2.49	$291.3K	117,000	SEC↗
Gibson Brian	Vice President	A Award deriv	2012-05-03	2012-05-07	305,000	$2.49	$759.5K	305,000	SEC↗
Bartel Ronnda	Chief Scientific Officer	A Award deriv	2012-05-03	2012-05-07	124,500	$2.49	$310.0K	124,500	SEC↗
Gibson Brian	Vice President	A Award deriv	2012-05-03	2012-05-15	195,000	$2.49	$485.6K	195,000	SEC↗
Durbin Scott	CFO	S Sale	2012-01-04	2012-01-06	40,000	$1.80	$72.0K	0	SEC↗